Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Response to CAR-T Therapy Can be Monitored Using Genome-Wide Sequencing of Cell-Free DNA in Patients with DLBCL

Aaron M Goodman, MD, Kimberly A Holden, Ah-Reum Jeong, MD, Lisa Kim, Kerry D Fitzgerald, PhD, Eyad Almasri, PhD, Graham McLennan, Marcia Eisenberg, PhD, Amin H Jahromi, Carl Hoh, Michael Hurley, Carolyn Mulroney, MD, Dimitrios Tzachanis, MD PhD, Edward D. Ball, MD, Taylor J Jensen, PhD BS, Razelle Kurzrock, MD

Blood (2020) 136 (Supplement 1): 17.

https://doi.org/10.1182/blood-2020-141010

Published: 2020

Journal Articles

Outcomes of Patients Requiring ICU Admission after CD19 Directed CAR T-Cells

Erica Lin, MD, Ah-Reum Jeong, MD, Michael Hurley, Robert L Owens, MD, Dimitrios Tzachanis, MD PhD, Aaron M Goodman, MD

Blood (2020) 136 (Supplement 1): 22.

https://doi.org/10.1182/blood-2020-140211

Published: 2020

Journal Articles

Differential Regulation of Myeloid Leukemias by the Bone Marrow Microenvironment

Daniela S. Krause, M.D., Ph.D., Keertik Fulzele, PhD, Andre Catic, MD PhD, Michael Hurley, Sanon Lezeau, Eyal C. Attar, MD, Joy Y. Wu, Herbert Yih-Fuu Lin, MD, PhD, Paola Divieti-Pajevic, MD PhD, Robert Hasserjian, MD, Ernestina Schipani, MD, Richard A. Van Etten, MD PhD, David T. Scadden, MD

Blood (2012) 120 (21): 1245.

https://doi.org/10.1182/blood.V120.21.1245.1245

Published: 2012

Journal Articles

Parathyroid Hormone-Induced Modulation of the Bone Marrow Microenvironment Reduces Leukemic Stem Cells in Murine Chronic Myelogenous-Leukemia-Like Disease Via a TGFbeta-Dependent Pathway

Daniela S. Krause, MD, PhD, Keertik Fulzele, PhD, Andre Catic, MD PhD, Michael Hurley, Sanon Lezeau, Robert Hasserjian, MD, Joy Wu, MD PhD, Paola Divieti-Pajevic, MD PhD, Richard A. Van Etten, MD PhD, Ernestina Schipani, MD, David T. Scadden, MD

Blood (2011) 118 (21): 1670.

https://doi.org/10.1182/blood.V118.21.1670.1670

Published: 2011

Journal Articles

Parathyroid Hormone-Induced Modulation of the Bone Marrow Microenvironment Inhibits the Development of Murine Chronic Myelogenous-Leukemia-Like Disease

Daniela S. Krause, MD, PhD, Sanon Lezeau, Michael Hurley, Ernestina Schipani, MD, David T. Scadden, MD

Blood (2010) 116 (21): 937.

https://doi.org/10.1182/blood.V116.21.937.937

Published: 2010

NARROW

Response to CAR-T Therapy Can be Monitored Using Genome-Wide Sequencing of Cell-Free DNA in Patients with DLBCL

Outcomes of Patients Requiring ICU Admission after CD19 Directed CAR T-Cells

Differential Regulation of Myeloid Leukemias by the Bone Marrow Microenvironment

Parathyroid Hormone-Induced Modulation of the Bone Marrow Microenvironment Reduces Leukemic Stem Cells in Murine Chronic Myelogenous-Leukemia-Like Disease Via a TGFbeta-Dependent Pathway

Parathyroid Hormone-Induced Modulation of the Bone Marrow Microenvironment Inhibits the Development of Murine Chronic Myelogenous-Leukemia-Like Disease

Email alerts

ASH Publications

American Society of Hematology

Response to CAR-T Therapy Can be Monitored Using Genome-Wide Sequencing of Cell-Free DNA in Patients with DLBCL

Outcomes of Patients Requiring ICU Admission after CD19 Directed CAR T-Cells

Differential Regulation of Myeloid Leukemias by the Bone Marrow Microenvironment

Parathyroid Hormone-Induced Modulation of the Bone Marrow Microenvironment Reduces Leukemic Stem Cells in Murine Chronic Myelogenous-Leukemia-Like Disease Via a TGFbeta-Dependent Pathway

Parathyroid Hormone-Induced Modulation of the Bone Marrow Microenvironment Inhibits the Development of Murine Chronic Myelogenous-Leukemia-Like Disease

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only